Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Allen

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Muscle & Nerve|May 19, 2021
Measuring treatment response to chronic inflammatory demyelinating polyneuropathy in clinical practice: More than just askingJeffrey A Allen
Neurology|September 20, 2022
SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the RiskJeffrey A Allen
Current Opinion in Neurology|June 14, 2024
New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines - impact on clinical practiseJeffrey A Allen
Neurology and Therapy|March 29, 2020
The Misdiagnosis of CIDP: A ReviewJeffrey A Allen
Continuum (Minneapolis, Minn.)|October 3, 2017
Chronic Demyelinating PolyneuropathiesJeffrey A Allen
Neurodegenerative Disease Management|May 28, 2016
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathyJeffrey A Allen, Vera Bril
Muscle & Nerve|November 25, 2014
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approachMelvin Berger, Jeffrey A Allen
Muscle & Nerve|August 22, 2022
Treatment of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Richard A Lewis
Muscle & Nerve|October 13, 2021
Could posturography be a useful outcome measure for chronic inflammatory demyelinating polyneuropathy?Karissa L Gable, Jeffrey A Allen
Muscle & Nerve|October 19, 2022
Diagnosis of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Richard A Lewis
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Muscle & Nerve|May 19, 2021
Measuring treatment response to chronic inflammatory demyelinating polyneuropathy in clinical practice: More than just askingJeffrey A Allen
Neurology|September 20, 2022
SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the RiskJeffrey A Allen
Current Opinion in Neurology|June 14, 2024
New chronic inflammatory demyelinating polyneuropathy/Guillain-Barré syndrome guidelines - impact on clinical practiseJeffrey A Allen
Neurology and Therapy|March 29, 2020
The Misdiagnosis of CIDP: A ReviewJeffrey A Allen
Continuum (Minneapolis, Minn.)|October 3, 2017
Chronic Demyelinating PolyneuropathiesJeffrey A Allen
Neurodegenerative Disease Management|May 28, 2016
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathyJeffrey A Allen, Vera Bril
Muscle & Nerve|November 25, 2014
Optimizing IgG therapy in chronic autoimmune neuropathies: a hypothesis driven approachMelvin Berger, Jeffrey A Allen
Muscle & Nerve|August 22, 2022
Treatment of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Richard A Lewis
Muscle & Nerve|October 13, 2021
Could posturography be a useful outcome measure for chronic inflammatory demyelinating polyneuropathy?Karissa L Gable, Jeffrey A Allen
Muscle & Nerve|October 19, 2022
Diagnosis of chronic inflammatory demyelinating polyneuropathyJeffrey A Allen, Richard A Lewis
Pageof 6